Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,252
  • Shares Outstanding, K 41,543
  • Annual Sales, $ 14,920 K
  • Annual Income, $ -86,880 K
  • 60-Month Beta 1.00
  • Price/Sales 3.65
  • Price/Cash Flow N/A
  • Price/Book 4.99
Trade CARM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.36
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.43
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +26.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +8.78%
on 05/23/24
1.6600 -18.74%
on 05/06/24
-0.2711 (-16.73%)
since 05/03/24
3-Month
1.2400 +8.78%
on 05/23/24
2.6700 -49.48%
on 03/07/24
-1.2411 (-47.92%)
since 03/01/24
52-Week
1.2400 +8.78%
on 05/23/24
9.7662 -86.19%
on 07/17/23
-5.0311 (-78.86%)
since 06/02/23

Most Recent Stories

More News
Carisma Therapeutics to Present at Upcoming Investor Conferences

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma Therapeutics" or the "Company"), a clinical stage biopharmaceutical company focused on...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3200 (-0.75%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing...

CARM : 1.3200 (-0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in...

See More

Key Turning Points

3rd Resistance Point 1.4442
2nd Resistance Point 1.3973
1st Resistance Point 1.3637
Last Price 1.3200
1st Support Level 1.2832
2nd Support Level 1.2363
3rd Support Level 1.2027

See More

52-Week High 9.7662
Fibonacci 61.8% 6.5092
Fibonacci 50% 5.5031
Fibonacci 38.2% 4.4970
Last Price 1.3200
52-Week Low 1.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar